Ibis Biosciences, Inc. develops, manufactures, and markets products for the identification and characterization of infectious agents.
It offers The Ibis T5000 Biosensor System, a hardware platform for the identification of biological organisms, including bacteria, viruses, fungi, and protozoa, as well as provides information about drug resistance, virulence, and strain type.
The company also provides assay kits and panels for strain genotyping and characterization. In addition, it supplies plates, buffers, and related consumables for PCR and various reagents for desalting. Further, the company offers assay services, such as human forensics and mitochondrial DNA assay services; bacterial and viral detection and profiling; and bacterial and viral surveillance services. Ibis Biosciences provides its products for use in applications, such as clinical research, healthcare-associated infection, surveillance, and forensics.
The company was incorporated in 2006 and is based in Carlsbad, California. As of January 6, 2009, Ibis Biosciences, Inc. operates as a subsidiary of Abbott Molecular Inc.
Current Team (1)Update
|Sep 14, 2009||CNet - Medical tools top WSJ's tech innovation awards - CNET|
|Sep 4, 2009||Reuters - Abbott Completes Acquisition of Ibis Biosciences, a Subsidiary of Isis|
1896 Rutherford Road
Carlsbad, CA 92008